Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision (v3.4.3) was added to the Record History, and the previous revision (v3.4.2) was removed.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:09.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and an older maintenance notice (v3.4.1) was removed; the changes pertain to site version updates and operating status notices. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T14:18:20.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice regarding government funding and the NIH Clinical Center status, and updated the release to Revision: v3.4.1 while removing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:29:38.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds a 'Show glossary' option and updates the descriptions of color-coded highlights. Revision notes are updated to v3.4.0 and the No FEAR Act data wording is adjusted.
    Difference
    0.9%
    Check dated 2026-01-28T06:21:03.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    New historical revision label v3.3.4 has been added, replacing the previous v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:58:50.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The history shows a new revision label (v3.3.3) added and the HHS Vulnerability Disclosure and Revision: v3.3.2 removed as administrative disclosures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:00:07.000Z thumbnail image

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.